Citadel Advisors’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5,900
Closed -$451K 13795
2025
Q4
$451K Buy
5,900
+100
+2% +$7.67K ﹤0.01% 9284
2025
Q3
$461K Buy
+5,800
New +$434K ﹤0.01% 9336
2025
Q2
Sell
-5,600
Closed -$414K 14205
2025
Q1
$414K Sell
5,600
-2,000
-26% -$141K ﹤0.01% 8898
2024
Q4
$527K Buy
7,600
+1,800
+31% +$137K ﹤0.01% 8439
2024
Q3
$488K Buy
5,800
+1,700
+41% +$131K ﹤0.01% 8308
2024
Q2
$278K Sell
4,100
-1,900
-32% -$122K ﹤0.01% 9290
2024
Q1
$377K Sell
6,000
-500
-8% -$28.2K ﹤0.01% 8979
2023
Q4
$363K Sell
6,500
-6,200
-49% -$328K ﹤0.01% 8761
2023
Q3
$652K Buy
12,700
+7,000
+123% +$366K ﹤0.01% 7477
2023
Q2
$299K Sell
5,700
-7,500
-57% -$386K ﹤0.01% 9061
2023
Q1
$681K Buy
13,200
+3,500
+36% +$191K ﹤0.01% 7641
2022
Q4
$507K Sell
9,700
-4,300
-31% -$236K ﹤0.01% 8208
2022
Q3
$791K Buy
14,000
+5,100
+57% +$321K ﹤0.01% 7491
2022
Q2
$539K Sell
8,900
-3,600
-29% -$205K ﹤0.01% 8471
2022
Q1
$738K Sell
12,500
-13,300
-52% -$757K ﹤0.01% 8440
2021
Q4
$1.48M Sell
25,800
-23,700
-48% -$1.31M ﹤0.01% 6912
2021
Q3
$2.65M Buy
49,500
+6,600
+15% +$412K ﹤0.01% 5659
2021
Q2
$2.88M Buy
42,900
+13,600
+46% +$948K ﹤0.01% 5703
2021
Q1
$2.12M Buy
29,300
+3,800
+15% +$265K ﹤0.01% 6256
2020
Q4
$1.76M Sell
25,500
-4,200
-14% -$267K ﹤0.01% 5615
2020
Q3
$1.79M Sell
29,700
-5,800
-16% -$358K ﹤0.01% 4922
2020
Q2
$2.16M Buy
35,500
+10,500
+42% +$577K ﹤0.01% 4437
2020
Q1
$1.24M Buy
25,000
+16,500
+194% +$1.25M ﹤0.01% 4946
2019
Q4
$693K Sell
8,500
-21,400
-72% -$1.75M ﹤0.01% 6268
2019
Q3
$2.46M Sell
29,900
-13,800
-32% -$1.12M ﹤0.01% 4146
2019
Q2
$3.41M Sell
43,700
-11,600
-21% -$901K ﹤0.01% 3661
2019
Q1
$4.34M Buy
55,300
+16,400
+42% +$1.3M ﹤0.01% 3207
2018
Q4
$2.94M Buy
38,900
+24,500
+170% +$1.85M ﹤0.01% 3546
2018
Q3
$1.09M Buy
14,400
+1,600
+13% +$122K ﹤0.01% 5396
2018
Q2
$943K Sell
12,800
-2,100
-14% -$148K ﹤0.01% 5323
2018
Q1
$1M Buy
14,900
+4,700
+46% +$321K ﹤0.01% 4804
2017
Q4
$769K Buy
10,200
+2,900
+40% +$225K ﹤0.01% 5035
2017
Q3
$564K Buy
7,300
+3,000
+70% +$235K ﹤0.01% 5148
2017
Q2
$341K Buy
4,300
+1,500
+54% +$113K ﹤0.01% 5704
2017
Q1
$203K Sell
2,800
-200
-7% -$14.7K ﹤0.01% 6505
2016
Q4
$223K Sell
3,000
-2,600
-46% -$191K ﹤0.01% 6142
2016
Q3
$439K Sell
5,600
-200
-3% -$15.7K ﹤0.01% 5054
2016
Q2
$436K Buy
+5,800
New +$403K ﹤0.01% 4685

Other funds holding NHI

Citadel Advisors's NHI Position: Q1 2026 in Review

Citadel Advisors increased its National Health Investors (NHI) stake by 266% in Q1 2026, buying an estimated $8.05M and bringing the position to 133,124 shares worth $10.8M. The position accounts for ﹤0.01% of the portfolio, ranked #3150.

Citadel Advisors first reported a position in NHI in Q2 2013 and has held it in 48 quarters since. The position peaked at $11.3M in Q4 2019. 318 funds tracked by Wall St. Rank hold NHI as of Q1 2026.

  • Citadel Advisors held 133,124 shares of National Health Investors worth $10.8M as of Q1 2026.
  • Citadel Advisors bought 96,706 National Health Investors shares in Q1 2026, an estimated $8.05M.
  • National Health Investors made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3150 holding.
  • Citadel Advisors first reported a position in National Health Investors in Q2 2013 and has held it in 48 quarters since.
  • Citadel Advisors's National Health Investors position peaked at $11.3M in Q4 2019.
  • 318 funds tracked by Wall St. Rank held National Health Investors as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.